Skip to main content
OpenTrials

Clinical trial condition

Prostatic Diseases

Explore clinical trials studying Prostatic Diseases. Study availability and eligibility vary by location and protocol.

5,335 public trials 1,046 recruiting studies
Refine in advanced search Browse all conditions

Prostatic Diseases trial results

Active, Not Recruiting

OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH

NCT06560476

Conditions
Benign Prostatic Hyperplasia, Genital Diseases, Genital Diseases, Male, +4 more
Locations
  • Florida Urology Partners Tampa, Florida, United States
  • Kearney Urology Center Kearney, Nebraska, United States
  • The Urology Center, P.C. Omaha, Nebraska, United States
  • Sheldon Freedman, Ltd Las Vegas, Nevada, United States
View Trial Details
Active, Not Recruiting

Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations

NCT05498272

Conditions
BRCA1 Mutation, BRCA2 Mutation, Genital Diseases, +12 more
Locations
  • University of California San Diego - Moores Cancer Center La Jolla, California, United States
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Columbia University Irving Medical Center New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Active, Not Recruiting

PSMA PET Imaging of Recurrent Prostate Cancer

NCT03204123

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Consent only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent only ) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Consent only) Commack, New York, United States
View Trial Details
Active, Not Recruiting

A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

NCT07047118

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +9 more
Locations
  • City of Hope National Medical Duarte, California, United States
  • Providence Saint Johns Health Ctr Santa Monica, California, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Yale University School Of Medicine New Haven, Connecticut, United States
View all 45 locations
View Trial Details
Active, Not Recruiting

Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)

NCT02319837

Conditions
Cancer of the Prostate, Genital Diseases, Genital Diseases, Male, +10 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham, IDS Pharmacy Birmingham, Alabama, United States
  • Alaska Urological Institute dba Alaska Clinical Research Center Anchorage, Alaska, United States
View all 255 locations
View Trial Details
Active, Not Recruiting

ProVIDE II Bridging Study

NCT06236802

Conditions
BPH With Symptomatic Lower Urinary Tract Symptoms, Genital Diseases, Genital Diseases, Male, +4 more
Locations
  • Florida Urology Partners, LLP Tampa, Florida, United States
  • Avant Concierge Urology Winter Garden, Florida, United States
  • Comprehensive Urologic Care Lake Barrington, Illinois, United States
  • Sheldon Freeman MD LTD Las Vegas, Nevada, United States
View Trial Details
Active, Not Recruiting

177Lu-PSMA-617 vs. Androgen Receptor-Directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer

NCT04689828

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +7 more
Locations
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • University of Florida Gainesville, Florida, United States
  • Tulane Uni Health Sciences Center New Orleans, Louisiana, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 72 locations
View Trial Details

Related conditions